首页> 外文期刊>European Journal of Pharmacology: An International Journal >Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.
【24h】

Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.

机译:蜂毒肽通过非磷脂酶介导的机制刺激脂肪酸释放,并与多巴胺转运蛋白和其他跨膜蛋白相互作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Phospholipase A(2) releases the fatty acid arachidonic acid from membrane phospholipids. We used the purported phospholipase A(2) stimulator, melittin, to examine the effects of endogenous arachidonic acid signaling on dopamine transporter function and trafficking. In HEK-293 cells stably transfected with the dopamine transporter, melittin reduced uptake of [((3))H]dopamine. Additionally, measurements of fatty acid content demonstrated a melittin-induced release of membrane-incorporated arachidonic acid, but inhibitors of phospholipase C, phospholipase D, and phospholipase A(2) did not prevent the release. Subsequent experiments measuring [(125)I]RTI-55 binding to the dopamine transporter demonstrated a direct interaction of melittin, or a melittin-activated endogenous compound, with the transporter to inhibit antagonist binding. This effect was not specific to the dopamine transporter, as [(3)H]spiperone binding to the recombinant dopamine D(2) receptor was also inhibited by melittin treatment. Finally, melittin stimulated an increase in internalization of the dopamine transporter, and this effect was blocked by pretreatment with cocaine. Thus, melittin acts through multiple mechanisms to regulate cellular activity, including release of membrane-incorporated fatty acids and interaction with the dopamine transporter.
机译:磷脂酶A(2)从膜磷脂中释放出脂肪酸花生四烯酸。我们使用了声称的磷脂酶A(2)刺激物蜂毒肽,以检查内源性花生四烯酸信号对多巴胺转运蛋白功能和贩运的影响。在用多巴胺转运蛋白稳定转染的HEK-293细胞中,蜂毒肽减少了[((3))H]多巴胺的摄取。此外,脂肪酸含量的测量表明蜂毒肽诱导释放的膜结合花生四烯酸,但磷脂酶C,磷脂酶D和磷脂酶A(2)的抑制剂不能阻止该释放。随后的测量[(125)I] -55与多巴胺转运蛋白结合的实验表明,蜂毒肽或蜂毒素活化的内源性化合物与转运蛋白直接相互作用,从而抑制拮抗剂的结合。此效果不是特定于多巴胺转运蛋白,因为[(3)H]哌咯酮与重组多巴胺D(2)受体的结合也受到蜂毒肽治疗的抑制。最后,蜂毒肽刺激多巴胺转运蛋白的内在化增加,而这种作用被可卡因预处理所阻断。因此,蜂毒素通过多种机制来调节细胞活性,包括膜结合脂肪酸的释放以及与多巴胺转运蛋白的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号